Novynette (Desogestrel, Ethinylestradiol)

Novynette combines desogestrel and ethinylestradiol to regulate hormonal pathways that prevent pregnancy.

• Contraception: Provides reliable, reversible prevention of pregnancy in women of childbearing age.
• Menstrual cycle regulation: Helps achieve more predictable menstrual bleeding patterns.
• Acne management: Reduces androgen‑driven skin lesions in women when prescribed for this purpose.
• Endometriosis symptom relief: Alleviates pain associated with endometrial tissue outside the uterus.
• Hormone replacement therapy adjunct: Used off‑label as part of hormone therapy regimens under specialist supervision.
• Polycystic ovary syndrome (PCOS) support: Assists in cycle regulation and androgen reduction when indicated.

• Desogestrel is a synthetic progestogen that binds to progesterone receptors, suppressing the luteinizing hormone surge and thereby inhibiting ovulation. Ethinylestradiol, a synthetic estrogen, provides negative feedback on the hypothalamic‑pituitary‑gonadal axis, stabilising the endometrial lining and enhancing contraceptive efficacy. Together, the combination modulates the menstrual cycle and prevents fertilisation.

Novynette may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nausea: Mild to moderate stomach upset.
• Headache: Tension‑type or migraine‑like pain.
• Breast tenderness: Temporary swelling or discomfort.
• Weight gain: Slight increase in body weight, often fluid‑related.
• Mood changes: Irritability or mild depressive symptoms.
• Spotting between periods: Light bleeding outside scheduled menses.

Serious or Rare Side Effects

• Venous thromboembolism: Blood clot formation in deep veins.
• Pulmonary embolism: Clot migration to lung arteries.
• Stroke: Cerebrovascular accident due to clot or hemorrhage.
• Myocardial infarction: Heart attack risk, especially in smokers.
• Severe allergic reaction: Anaphylaxis with rash, swelling, or breathing difficulty.
• Liver dysfunction: Jaundice or abnormal liver enzyme levels.

Before prescribing Novynette, clinicians should evaluate individual risk factors and counsel patients on safe use.

• Smoking status: Avoid use in women over 35 who smoke due to increased thrombotic risk.
• Cardiovascular history: Assess for hypertension, heart disease, or stroke history.
• Migraine with aura: Contraindicated in patients experiencing aura‑type migraines.
• Liver disease: Use with caution in hepatic impairment.
• Pregnancy intention: Advise discontinuation if pregnancy is desired.
• Store at ambient temperature: Keep below 25°C in the original packaging, protected from moisture.

Novynette can interact with several medicines that affect hormone metabolism or clotting pathways.

Major Interactions (Avoid)

• Antifungal agents (e.g., ketoconazole): Increase estrogen levels, raising clot risk.
• Antiretroviral drugs (e.g., ritonavir): Decrease contraceptive effectiveness.
• Enzyme inducers (e.g., rifampicin): Lower hormone concentrations, reducing efficacy.

Moderate Interactions (Monitor Closely)

• Antidepressants (SSRIs): May increase bleeding tendency.
• Anticonvulsants (phenytoin, carbamazepine): Potentially reduce hormone levels.
• Herbal supplements (St. St                                                                                                                                                                                                                                                                                                                                                                                                                                                                    ...